TL;DR: Ritivel does not publish a price list we can verify, which is normal for Healthcare companies at this stage. Below: what we can confirm, how to get a real quote, and 8 comparable tools to benchmark the number against.
What is verifiable about Ritivel pricing, how to get a real quote, and 8 comparable tools to price it against.
Last verified:
Not in any source we can verify. Ritivel is a Y Combinator-backed Healthcare company from the Winter 2026 batch, and companies at this stage usually quote per customer rather than publish rate cards. We will not guess at a number — anything quoted elsewhere without a source is guesswork too. The company profile we work from is the Y Combinator listing; the current figure has to come from Ritivel directly.
These are the closest comparable tools, matched on what Ritivel actually does. Price each one alongside it — stage and team size are a reasonable proxy for where a vendor sits on price.
| Compare against | What it does | Stage | Team |
|---|---|---|---|
| Biocogniv | — | YC Summer 2020 | 6 |
| Docbot | — | YC Winter 2019 | — |
| Atlas Discovery | AI-native pharma company | YC Summer 2026 | 3 |
| Verifiable | API for healthcare compliance | YC Summer 2020 | 12 |
| Mind Emulation Foundation | — | YC Winter 2018 | 1 |
| Candid Health | The autonomous revenue cycle management platform. | YC Winter 2020 | 200 |
| Semantix | AI for medical billing | YC Summer 2017 | 2 |
| Quinn | The AI that delivers pharma R&D decisions in days, not months | YC Summer 2022 | 4 |
That depends on a number we cannot see, so judge it on what we can: Ritivel is currently Active with a team of around 3. A small team means faster support and more negotiating room, but more risk of the product changing direction. A larger or public vendor costs more and moves slower. If price is the deciding factor, the earlier-batch companies in the table are usually the ones still competing on it.
See all Ritivel alternatives compared →
Built by LemStudio
Loading interactive view…